Shan J - Search Results

1

Treatment of Philadelphia chromosome-positive chronic myelogenous leukemia with weekly polyethylene glycol formulation of interferon-alpha-2b and low-dose cytosine arabinoside.

Garcia-Manero G, Talpaz M, Giles FJ, Cortes J, Faderl S, O'Brien S, Thomas D, Verstovsek S, Beth Rios M, Shan J, Ferrajoli A, Wierda W, Kantarjian HM. Garcia-Manero G, et al. Among authors: shan j. Cancer. 2003 Jun 15;97(12):3010-6. doi: 10.1002/cncr.11424. Cancer. 2003. PMID: 12784336 Free article. Clinical Trial.

2

Sudden onset of the blastic phase of chronic myelogenous leukemia: patterns and implications.

Kantarjian H, O'Brien S, Cortes J, Giles F, Thomas D, Kornblau S, Shan J, Beth Rios M, Keating M, Freireich E, Talpaz M. Kantarjian H, et al. Among authors: shan j. Cancer. 2003 Jul 1;98(1):81-5. doi: 10.1002/cncr.11477. Cancer. 2003. PMID: 12833459 Free article.

3

Effects of age on prognosis with imatinib mesylate therapy for patients with Philadelphia chromosome-positive chronic myelogenous leukemia.

Cortes J, Talpaz M, O'Brien S, Giles F, Beth Rios M, Shan J, Faderl S, Garcia-Manero G, Ferrajoli A, Wierda W, Kantarjian H. Cortes J, et al. Among authors: shan j. Cancer. 2003 Sep 15;98(6):1105-13. doi: 10.1002/cncr.11629. Cancer. 2003. PMID: 12973833 Free article.

4

Erythropoietin is effective in improving the anemia induced by imatinib mesylate therapy in patients with chronic myeloid leukemia in chronic phase.

Cortes J, O'Brien S, Quintas A, Giles F, Shan J, Rios MB, Talpaz M, Kantarjian H. Cortes J, et al. Among authors: shan j. Cancer. 2004 Jun 1;100(11):2396-402. doi: 10.1002/cncr.20292. Cancer. 2004. PMID: 15160343 Free article.

5

Clinical impact of dose reductions and interruptions of second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukaemia.

Santos FP, Kantarjian H, Fava C, O'Brien S, Garcia-Manero G, Ravandi F, Wierda W, Thomas D, Shan J, Cortes J. Santos FP, et al. Among authors: shan j. Br J Haematol. 2010 Aug;150(3):303-12. doi: 10.1111/j.1365-2141.2010.08245.x. Epub 2010 Jun 10. Br J Haematol. 2010. PMID: 20553275 Free PMC article.

6

Defining the course and prognosis of adults with acute lymphocytic leukemia in first salvage after induction failure or short first remission duration.

Kantarjian HM, Thomas D, Ravandi F, Faderl S, Jabbour E, Garcia-Manero G, Pierce S, Shan J, Cortes J, O'Brien S. Kantarjian HM, et al. Among authors: shan j. Cancer. 2010 Dec 15;116(24):5568-74. doi: 10.1002/cncr.25354. Epub 2010 Aug 24. Cancer. 2010. PMID: 20737576 Free PMC article.

7

Phase 1 study of polyethylene glycol formulation of interferon alpha-2B (Schering 54031) in Philadelphia chromosome-positive chronic myelogenous leukemia.

Talpaz M, O'Brien S, Rose E, Gupta S, Shan J, Cortes J, Giles FJ, Faderl S, Kantarjian HM. Talpaz M, et al. Among authors: shan j. Blood. 2001 Sep 15;98(6):1708-13. doi: 10.1182/blood.v98.6.1708. Blood. 2001. PMID: 11535501 Free article. Clinical Trial.

8

Response to therapy is independently associated with survival prolongation in chronic myelogenous leukemia in the blastic phase.

Kantarjian HM, Shan J, Smith T, Talpaz M, Kozuch P, Rios MB, Cortes J, Giles FJ, O'Brien S. Kantarjian HM, et al. Among authors: shan j. Cancer. 2001 Nov 15;92(10):2501-7. doi: 10.1002/1097-0142(20011115)92:10<2501::aid-cncr1600>3.0.co;2-n. Cancer. 2001. PMID: 11745182

9

Outcome of adults with acute lymphocytic leukemia in second or subsequent complete remission.

Kantarjian HM, Thomas D, Ravandi F, Faderl S, Garcia-Manero G, Shan J, Pierce S, Cortes J, O'Brien S. Kantarjian HM, et al. Among authors: shan j. Leuk Lymphoma. 2010 Mar;51(3):475-80. doi: 10.3109/10428190903503412. Epub 2010 Jan 18. Leuk Lymphoma. 2010. PMID: 20078325 Free PMC article.

10

A prospective randomized study of alpha-2b interferon plus hydroxyurea or cytarabine for patients with early chronic phase chronic myelogenous leukemia: the International Oncology Study Group CML1 study.

Giles FJ, Shan J, Chen S, Advani SH, Supandiman I, Aziz Z, Caviles AP, Tee GY, Chasen MR, Fahed Z, Chaoj TY, Aydogdu I, Lynott AM. Giles FJ, et al. Among authors: shan j. Leuk Lymphoma. 2000 Apr;37(3-4):367-77. doi: 10.3109/10428190009089437. Leuk Lymphoma. 2000. PMID: 10752988 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,131 results

Search Page

Filters